Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Buy
38,079
+5,535
+17% +$258K 0.13% 133
2025
Q4
$1.58M Buy
32,544
+2,283
+8% +$113K 0.11% 140
2025
Q3
$1.43M Buy
30,261
+2,919
+11% +$141K 0.19% 100
2025
Q2
$1.32M Sell
27,342
-1,076
-4% -$55K 0.1% 152
2025
Q1
$1.58M Buy
28,418
+1,749
+7% +$94.7K 0.23% 89
2024
Q4
$1.29M Buy
26,669
+1,487
+6% +$75.6K 0.12% 132
2024
Q3
$1.45M Buy
25,182
+1,438
+6% +$77.6K 0.13% 121
2024
Q2
$1.15M Sell
23,744
-21
-0.1% -$1.01K 0.12% 131
2024
Q1
$1.15M Buy
+23,765
New +$1.16M 0.12% 135

Other funds holding SNY

Leo Wealth LLC's SNY Position: Q1 2026 in Review

Leo Wealth LLC increased its Sanofi (SNY) stake by 17% in Q1 2026, buying an estimated $258K and bringing the position to 38,079 shares worth $1.83M. The position accounts for 0.13% of the portfolio, ranked #133.

Leo Wealth LLC first reported a position in SNY in Q1 2024 and has held it in 9 quarters since. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Leo Wealth LLC held 38,079 shares of Sanofi worth $1.83M as of Q1 2026.
  • Leo Wealth LLC bought 5,535 Sanofi shares in Q1 2026, an estimated $258K.
  • Sanofi made up 0.13% of Leo Wealth LLC's portfolio in Q1 2026, its #133 holding.
  • Leo Wealth LLC first reported a position in Sanofi in Q1 2024 and has held it in 9 quarters since.
  • 745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.